Biobanks Market Size & Share | Industry Forecast 2021, 2028
Market Insights
The global biobanks market generated US$ 2,418.31 million in 2021 and is anticipated to account for US$ 3,758.64 million by 2028, expanding at a CAGR of 6.5% during 2021–2028.
The growing funding and genomic research activities for studying diseases, increasing pharmaceutical and biopharmaceutical R&D expenses, and the rising adoption of regenerative medicines are the potential aspects proliferating the biobanks market growth. On the contrary, the high cost of automation hinders the expansion of global biobanks market.
A biobank offers collection of biological samples (such as blood) as well as healthcare data. Biobanks might be vast, including thousands of samples, or small, containing only a few hundred. Different samples and information are collected by different biobanks to evaluate specific functions. Major market players have optimized their growth with several organic and inorganic growth strategies.
Regionally, North America held the largest share of the global biobanks market and is likely to retain its dominance over the forecast period. Asia Pacific is speculated to spur with the highest CAGR during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Global Biobanks Market: Strategic Insights
Market Size Value in US$ 2,418.31 Million in 2021 Market Size Value by US$ 3,758.64 Million by 2028 Growth rate CAGR of 6.5% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Global Biobanks Market: Strategic Insights
| Market Size Value in | US$ 2,418.31 Million in 2021 |
| Market Size Value by | US$ 3,758.64 Million by 2028 |
| Growth rate | CAGR of 6.5% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
COVID-19 Impact
The Application in Sampling, Analysis, and Vaccine Creation Aid the Global Biobanks Market Growth
The global COVID-19 pandemic had far-reaching health-care, economic, and societal consequences around the world. The health-care system in North America faced an immediate issue in estimating the demographics of COVID-19 impact. In the early stage of pandemic, biobanking activities in Canada were considered as non-essential health care services, but with the emergence of research operations, the disease-related studies were permitted and published. The US leveraged virtual care and remote monitoring strategy to assure patients of having full clinical support. Biobanking became a necessary service during pandemic facilitating quicker critical research operations. Global biobanks had to purchase extra personal protective equipment (PPE) kits to safeguard medical personnel from infection. Also, they communicated globally for the material required to collect and store specimens.
In Europe, biobanks proved to be extremely helpful to mitigate COVID-19 as they provided researchers with necessary samples to assess the conditions and create vaccines and therapies. Biobanks played a vital role during pandemic in research, sampling, and vaccination. It would have been impossible to make the genome of the SARS-CoV-2 virus accessible to the entire scientific community and produce vaccination in record time without samples collected from infected patients. Asia pacific biobanks market, which was plagued by ethical difficulties and infrastructure challenges, is likely to grow rapidly in future. The Indian Council of Medical Research (ICMR) approved 16 bio-repositories to collect, store, and keep clinical samples from COVID infected patients.
Future Trends
Virtual Biobanks
A virtual repository provides data extracted and characterized from samples stored in traditional biobank.Virtual biobank’s database offers high-resolution images of samples and other characteristic data. These biobanks can be accessed via specialized software or a web portal. They allow access to recorded data formats negating the requirement of physical samples. Virtual biobanks, often used in bioinformatics, contains 2D and 3D microscopy datasets of valuable clinical biopsy specimens. This system has emerged as a practical option to improve sample visibility and access. Researchers can use virtual biobanks to identify products and services they need to simplify and manage critical phases of the biobanking process. Virtual system integration is likely to bolster the global biobanks market in future.
Drivers
Growing Funding and Genomic Research Activities for Studying Diseases
Genomic sequencing is rapidly transitioning into clinical practice and healthcare systems with an aid of substantial government investments. The national genomic-medicine initiatives are driving transformative changes in medical systems. The UK has announced world’s largest genome project as a part of 200 million public-private collaborations between charities and pharma. The project will fund researchers and industry to combine data and real-world evidence from UK health services. Boston, a Massachusetts-based company received a US$ 4.3 million in seed funding to partner with Veritas Genetics, a genome sequencing company. Biobank has been a significant resource for genomic research on infectious diseases and hosts. Data from biobanks help understand the etiology of multifactorial diseases caused by genetic mutations.
Rising Adoption of Regenerative Medicines
Regenerative therapies help induce the regeneration of cells, tissues, and organs to restore their functions. The Food and Drug Administration (FDA) receives a large number of regenerative medicine applications for human clinical trials every year. Rapid advancements in regenerative medicines to bring out effective solutions for chronic conditions potentially drive the global biobanks market growth. Cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis Kymriah was the first cell therapy solution to treat B-cell acute leukemia. Biobank has been a major asset for regenerative medicines as it provides material for research, development, and therapy. Investing in biobanking can yield considerable cost recoveries to support regenerative medicines and tissue engineering program.
Restraints
High Cost of Automation
Expensive automation has been a major impediment to the growth of global biobanks market. The advanced features and functions have made biospecimen storage instruments high-priced. Also, since the cost of biobanking operations is not limited to automation, companies assess various factors influencing their overall financial stability. The total expenditure of automation include cost of purchasing equipment, other infrastructures, and process improvements as per demand. Automated systems can cost five to ten times the expenses of manual operations in the beginning. For completely maintained automation, the ten-year operating cost is expected to range between US$ 0.57 to 5.66 million. Research companies are paying more for the automation incorporation. Such highly expensive automated systems are likely to curtail the growth of global biobanks market.
Market Segmentation
By Product and Service
Requirement for Storage and Handling Spurred the Segmental Growth
The global biobanks market, by product and service, is split into equipment, consumables, services, and software. The equipment segment occupied the largest market share in 2021 and will continue to dominate till 2028. Equipment plays a vital role in the manufacturing of biobank products. It is crucial at every stage of storage. Therefore, the biomaterial storage, handling, and research management requires different types of equipment. The segment is further categorized into storage, sample analysis, sample processing, and sample transport equipment.
Consumables, the second-largest market captivator is also anticipated to grow with the highest CAGR for the forecast period. Consumables such as petri dishes, test tubes, pipettes, and beakers are used at every step of sample collection, preparation, analysis, storage, and transportation. Besides, they are also required at the time of QC process to assure appropriate testing. The segmental growth is largely accustomed to the use of consumables in research and academic institutes and life science companies.
By Sample
Requirement in Sampling and Analysis Strengthened the Segment’s Dominance
Based on sample, the global biobanks market is segmented into blood products, human tissues, cell lines, and others. In 2021, the blood products segment dominated the market with the largest revenue share and is expected to soar at the highest CAGR during 2021–2028. Blood is one of the most common bio-samples collected in human biobanks for being the source of DNA and RNA. The buffy coat and whole blood samples are required for biobanks in human biospecimens.
Cell lines segment follows blood products to occupy second-largest market share. Patient-derived cell lines are essential for fundamental research, high-throughput drug screenings, and assessment of new pharmaceutical agents. The role of biobanks is crucial in maintaining human embryonic stem cell lines in stem cell research. Many cell lines are unique in nature, for example, induced pluripotent stem cells obtained from patients with Down Syndrome.
Regional Insights
Geographically, the global biobanks market is segmented into North America, Europe, Asia Pacific (APAC), South & Central America (SCAM), and Middle East & Africa (MEA).
North America encompassed the largest market share in 2021 and is projected to retain its dominance till 2028. A highly structured healthcare industry, early acceptance of breakthrough products, prevalence of chronic diseases, breakthroughs in drug discovery, rising investments by government and non-government organizations, and the presence of key players are the potential parameters driving the regional biobanks market. In the US, the regenerative medicine research is getting more focused and advanced making disease reversal feasible. It has been observed that stem cells have the potential to treat a wide range of diseases that were previously considered untreatable. Expanding research institutes, growing interest among students and researchers in various genetic investigations, investment by global firms, and government initiatives are the primary aspects elevating the Canada biobanks market growth.
Asia Pacific biobanks market is likely to expand with the highest CAGR over the forecast period. Biobanking is one of many initiatives aimed at preserving biological resources and data for future research and development in the region. China, particularly has been very active in biobanking activities as a part of government co-ordinated strategic programs. The country has also established a network of Asian biobanks ahead of time to ensure resource and expertise sharing. To develop stable operation systems, biobanks in the APAC standardize operational procedures and diversify financial sources. Indian government sponsored translational research institutes to treat variety of diseases, making country more innovative and sustainable.
Biobanks Market Report Scope
Key Market Players:
- Thermo Fisher Scientific Inc (US)
- Tecan Trading AG (Switzerland)
- QIAGEN (Netherlands)
- Hamilton Company (US)
- Avantor, Inc (US)
- Micronics Japan Co., Ltd. (Japan)
- BD (US)
- Taylor-Wharton (US)
- Brooks Automation, Inc (US)
- Biovault Family (UK)
- Promega Corporation (US)
- SciSafe Inc. (US)
Key Developments:
December 2021:
Thermo Fisher Scientific Inc acquired PPD, Inc., a leading global provider of clinical research services, for US$ 17.4 billion.August 2021:
Tecan Group completed the acquisition of US-based Paramit Corporation and its affiliates for a total purchase consideration of US$ 1.0 billion.January 2022:
QIAGEN announced new additions to the growing number of applications for QI Acuity, its ultrasensitive digital PCR platform that uses nanoplates to process samples in just two hours.July 2021:
BD acquired Tepha Inc., a leading developer and manufacturer of a proprietary resorbable polymer technology.
Report Coverage
The global biobanks market research report provides detailed insights into the market in terms of size, share, trends, and forecasts. It delivers crisp and precise know-how of drivers, restraints, opportunities, segments, and industrial landscape. The COVID-19 impact analysis is discussed with the opportunities observed in global and regional markets. A list of key market players with their respective developments in recent years has been reserved as a special mention.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product and Service, Sample, and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The blood products segment dominated the global biobanks market and accounted for the largest market share of 75.47% in 2021.
A biobank is a collection of biological samples (such as blood) as well as health data. Biobanks might be vast, including thousands of samples, or small, containing only a few hundred. Different sorts of samples and information are collected by different biobanks. The information and samples gathered are determined by the biobank's specific function. The term biobank covers collections of plants and animals, including human specimens.
Key factors that are driving the growth of this market are the growing funding and genomic research activities for studying diseases, increasing pharmaceutical and biopharmaceutical R&D expenditures, and rising adoption of regenerative medicines are expected to boost the market growth for the biobanks over the years.
The CAGR value of the biobanks market during the forecasted period of 2021-2028 is 6.5%.
The equipment segment held the largest share of the market in the global biobanks market and held the largest market share of 54.38% in 2021.
The regenerative medicine segment dominated the global biobanks market and accounted for the largest market share of 48.92% in 2021.
The biobanks market majorly consists of players such Thermo Fisher Scientific Inc., Tecan Trading AG, QIAGEN, Hamilton Company, Avantor, Inc., Micronics Japan Co.,Ltd., BD, Taylor-Wharton, Brooks Automation, Inc., Biovault Family, Promega Corporation, and SciSafe Inc. amongst others.
Hamilton Company. and Avantor, Inc. are the top two companies that hold huge market shares in the Biobanks market.
Global biobanks market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share for biobanks in 2021. The United States held the largest market in North America for biobanks, and the market is expected to grow due to the increasing adoption of technological advancements and rising innovations in regenerative medicine are projected to accelerate the growth of the biobanks market.
Biobanking became a necessary service as a result of this development, allowing for faster COVID-19 research and the continuation of critical research operations. During the epidemic, navigating the scarce and frequently competing healthcare supply chains was critical for continuous operational demands. Global biobanks have had to purchase extra personal protective equipment (PPE) to safeguard their personnel from COVID-19, and even employees have had to be regularly checked for suspected COVID-19 symptoms. Biobanks had to communicate and search globally for the materials they required to quickly collect and store specimens. Biobanks are critical in collecting and preserving bio samples such as plasma, serum, DNA and RNA, clinical data, and genomic data due to the large number of clinical trials related to COVID-19.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Biobanks Market – By Product and Service
1.3.2 Global Biobanks Market – By Sample
1.3.3 Global Biobanks Market – By Application
1.3.4 Global Biobanks Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Biobanks Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Biobanks Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Funding and Genomic Research Activities for Studying Diseases
5.1.2 Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures
5.1.3 Rising Adoption of Regenerative Medicines
5.2 Market Restraints
5.2.1 High Cost of Automation
5.3 Market Opportunities
5.3.1 Increasing Adoption of Cell Therapy in Developing Regions
5.4 Future Trends
5.4.1 Virtual Biobanks
5.5 Impact Analysis
6. Biobanks Market– Global Analysis
6.1 Global Biobanks Market Revenue Forecast and Analysis
6.2 Global Biobanks Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Biobanks Market Revenue and Forecasts To 2028– by Product and Service
7.1 Overview
7.2 Global Biobanks Market, By Product and Service, 2021 & 2028 (%)
7.3 Equipment
7.3.1 Overview
7.3.2 Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
7.3.2.1 Storage Equipment
7.3.2.1.1 Overview
7.3.2.1.2 Storage Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Sample Analysis Equipment
7.3.2.2.1 Overview
7.3.2.2.2 Sample Analysis Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Sample Processing Equipment
7.3.2.3.1 Overview
7.3.2.3.2 Sample Processing Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.4 Sample Transport Equipment
7.3.2.4.1 Overview
7.3.2.4.2 Sample Transport Equipment: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
7.4.2.1 Storage Consumables
7.4.2.1.1 Overview
7.4.2.1.2 Storage Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Analysis Consumables
7.4.2.2.1 Overview
7.4.2.2.2 Analysis Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4.2.3 Processing Consumables
7.4.2.3.1 Overview
7.4.2.3.2 Processing Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.4.2.4 Collection Consumables
7.4.2.4.1 Overview
7.4.2.4.2 Collection Consumables: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5 Services
7.5.1 Overview
7.5.2 Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
7.5.2.1 Storage Services
7.5.2.1.1 Overview
7.5.2.1.2 Storage Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Processing Services
7.5.2.2.1 Overview
7.5.2.2.2 Processing Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Transport Services
7.5.2.3.1 Overview
7.5.2.3.2 Transport Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.5.2.4 Supply Services
7.5.2.4.1 Overview
7.5.2.4.2 Supply Services: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
8. Biobanks Market Revenue and Forecasts To 2028 – Sample
8.1 Overview
8.2 Global Biobanks Market Share by Application - 2021 & 2028 (%)
8.3 Blood Products
8.3.1 Overview
8.3.2 Blood Products: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
8.4 Human Tissues
8.4.1 Overview
8.4.2 Human Tissues: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
8.5 Cell Lines
8.5.1 Overview
8.5.2 Cell Lines: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
9. Biobanks Market Revenue and Forecasts To 2028 – Application
9.1 Overview
9.2 Global Biobanks Market Share by Application - 2021 & 2028 (%)
9.3 Regenerative Medicine
9.3.1 Overview
9.3.2 Regenerative Medicine: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
9.4 Life Science Research
9.4.1 Overview
9.4.2 Life Science Research: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
9.5 Clinical Research
9.5.1 Overview
9.5.2 Clinical Research: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
10. Biobanks Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 North America: Biobanks Market
10.1.1 Overview
10.1.2 North America: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Biobanks Market, by Product- 2019–2028 (USD Million)
10.1.3.1 North America: Biobanks Market, by Equipment- 2019–2028 (USD Million)
10.1.3.2 North America: Biobanks Market, by Consumables- 2019–2028 (USD Million)
10.1.3.3 North America: Biobanks Market, by Services- 2019–2028 (USD Million)
10.1.4 North America: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.5 North America: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.6 North America: Biobanks Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3 US: Biobanks Market, by Product, 2019–2028 (USD Million)
10.1.6.1.3.1 US: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.6.1.3.2 US: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.6.1.3.3 US: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.6.1.4 US: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.6.1.5 US: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.6.2 Canada: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3 Canada: Biobanks Market, by Product- 2019–2028 (USD Million)
10.1.6.2.3.1 Canada: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.6.2.3.2 Canada: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.6.2.3.3 Canada: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.6.2.4 Canada: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.6.2.5 Canada: Biobanks Market, by Application, 2019–2028 (USD Million)
10.1.6.3 Mexico: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3 Mexico: Biobanks Market, by Product, 2019–2028 (USD Million)
10.1.6.3.3.1 Mexico: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.1.6.3.3.2 Mexico: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.1.6.3.3.3 Mexico: Biobanks Market, by Services, 2019–2028 (USD Million)
10.1.6.3.4 Mexico: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.1.6.3.5 Mexico: Biobanks Market, by Application, 2019–2028 (USD Million)
10.2 Europe: Biobanks Market
10.2.1 Overview
10.2.2 Europe: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
10.2.3.1 Europe: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.2.3.2 Europe: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.2.3.3 Europe: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.2.4 Europe: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Biobanks Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3.1 Germany: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.2.6.1.3.2 Germany: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.2.6.1.3.3 Germany: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.2.6.1.4 Germany: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.5 Germany: Biobanks Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 France: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 France: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3.1 France: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.2.6.2.3.2 France: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.2.6.2.3.3 France: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.2.6.2.4 France: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.5 France: Biobanks Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 UK: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 UK: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3.1 UK: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.2.6.3.3.2 UK: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.2.6.3.3.3 UK: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.2.6.3.4 UK: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.5 UK: Biobanks Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Italy: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3.1 Italy: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.2.6.4.3.2 Italy: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.2.6.4.3.3 Italy: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.2.6.4.4 Italy: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.5 Italy: Biobanks Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Spain: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3.1 Spain: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.2.6.5.3.2 Spain: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.2.6.5.3.3 Spain: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.2.6.5.4 Spain: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.5 Spain: Biobanks Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3.1 Rest of Europe: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.2.6.6.3.2 Rest of Europe: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.2.6.6.3.3 Rest of Europe: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific: Biobanks Market
10.3.1 Overview
10.3.2 Asia Pacific: Biobanks Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Biobanks Market, by Product, 2019–2028 (USD Million)
10.3.3.1 Asia Pacific: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.3.3.2 Asia Pacific: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.3.3.3 Asia Pacific: Biobanks Market, by Services, 2019–2028 (USD Million)
10.3.4 Asia Pacific: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.3.5 Asia Pacific: Biobanks Market, by Application, 2019–2028 (USD Million)
10.3.6 Asia Pacific: Biobanks Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.3 China: Biobanks Market, by Product, 2019–2028 (USD Million)
10.3.6.1.3.1 China: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.3.6.1.3.2 China: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.3.6.1.3.3 China: Biobanks Market, by Services, 2019–2028 (USD Million)
10.3.6.1.4 China: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.3.6.1.5 China: Biobanks Market, by Application, 2019–2028 (USD Million)
10.3.6.2 Japan: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.3 Japan: Biobanks Market, by Product, 2019–2028 (USD Million)
10.3.6.2.3.1 Japan: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.3.6.2.3.2 Japan: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.3.6.2.3.3 Japan: Biobanks Market, by Services, 2019–2028 (USD Million)
10.3.6.2.4 Japan: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.3.6.2.5 Japan: Biobanks Market, by Application, 2019–2028 (USD Million)
10.3.6.3 India: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.3 India: Biobanks Market, by Product, 2019–2028 (USD Million)
10.3.6.3.3.1 India: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.3.6.3.3.2 India: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.3.6.3.3.3 India: Biobanks Market, by Services, 2019–2028 (USD Million)
10.3.6.3.4 India: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.3.6.3.5 India: Biobanks Market, by Application, 2019–2028 (USD Million)
10.3.6.4 South Korea: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.3 South Korea: Biobanks Market, by Product, 2019–2028 (USD Million)
10.3.6.4.3.1 South Korea: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.3.6.4.3.2 South Korea: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.3.6.4.3.3 South Korea: Biobanks Market, by Services, 2019–2028 (USD Million)
10.3.6.4.4 South Korea: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.3.6.4.5 South Korea: Biobanks Market, by Application, 2019–2028 (USD Million)
10.3.6.5 Australia: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.3 Australia: Biobanks Market, by Product, 2019–2028 (USD Million)
10.3.6.5.3.1 Australia: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.3.6.5.3.2 Australia: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.3.6.5.3.3 Australia: Biobanks Market, by Services, 2019–2028 (USD Million)
10.3.6.5.4 Australia: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.3.6.5.5 Australia: Biobanks Market, by Application, 2019–2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Biobanks Market, by Product, 2019–2028 (USD Million)
10.3.6.6.3.1 Rest of Asia Pacific: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.3.6.6.3.2 Rest of Asia Pacific: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.3.6.6.3.3 Rest of Asia Pacific: Biobanks Market, by Services, 2019–2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.3.6.6.5 Rest of Asia Pacific: Biobanks Market, by Application, 2019–2028 (USD Million)
10.4 Middle East & Africa Biobanks Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 Middle East & Africa Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
10.4.3 Middle East & Africa: Biobanks Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
10.4.3.1 Middle East & Africa: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.4.3.2 Middle East & Africa: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.4.3.3 Middle East & Africa: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.4.4 Middle East & Africa: Biobanks Market Revenue and Forecasts to 2028, By Sample (US$ Million)
10.4.5 Middle East & Africa: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.4.6 Middle East & Africa Biobanks Market Revenue and Forecasts to 2028, By Country (%)
10.4.6.1 UAE: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
10.4.7 Overview
10.4.7.1.1 UAE: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
10.4.7.1.2 UAE: Biobanks Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
10.4.7.1.2.1 UAE: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.4.7.1.2.2 UAE: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.4.7.1.2.3 UAE: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.4.7.1.3 UAE: Biobanks Market Revenue and Forecasts To 2028, By Sample (US$ Million)
10.4.7.1.4 UAE: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.4.7.2 Saudi Arabia: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
10.4.7.2.1 Overview
10.4.7.2.2 Saudi Arabia: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
10.4.7.2.3 Saudi Arabia: Biobanks Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
10.4.7.2.3.1 Saudi Arabia: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.4.7.2.3.2 Saudi Arabia: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.4.7.2.3.3 Saudi Arabia: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.4.7.2.4 Saudi Arabia: Biobanks Market Revenue and Forecasts To 2028, By Sample (US$ Million)
10.4.7.2.5 Saudi Arabia: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.4.7.3 South Africa: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
10.4.7.3.1 Overview
10.4.7.3.2 South Africa Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
10.4.7.3.3 South Africa: Biobanks Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
10.4.7.3.3.1 South Africa: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.4.7.3.3.2 South Africa: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.4.7.3.3.3 South Africa: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.4.7.3.4 South Africa: Biobanks Market Revenue and Forecasts To 2028, By Sample (US$ Million)
10.4.7.3.5 South Africa: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.4.7.4 Rest of Middle East and Africa: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
10.4.7.4.1 Overview
10.4.7.4.2 Rest of Middle East and Africa: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
10.4.7.4.3 Rest of Middle East & Africa: Biobanks Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
10.4.7.4.3.1 Rest of Middle East & Africa: Biobanks Market, by Equipment, 2019–2028 (US$ Million)
10.4.7.4.3.2 Rest of Middle East & Africa: Biobanks Market, by Consumables, 2019–2028 (US$ Million)
10.4.7.4.3.3 Rest of Middle East & Africa: Biobanks Market, by Services, 2019–2028 (US$ Million)
10.4.7.4.4 Rest of Middle East & Africa: Biobanks Market Revenue and Forecasts To 2028, By Sample (US$ Million)
10.4.7.4.5 Rest of Middle East and Africa: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.5 South And Central America Biobanks Market Revenue and Forecasts To 2028
10.5.1 Overview
10.5.2 South and Central America: Biobanks Market - Revenue and Forecast to 2028 (USD Million)
10.5.2.1.1 South and Central America: Biobanks Market, by Product, 2019–2028 (USD Million)
10.5.2.1.1.1 South and Central America: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.5.2.1.1.2 South and Central America: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.5.2.1.1.3 South and Central America: Biobanks Market, by Services, 2019–2028 (USD Million)
10.5.2.1.2 South and Central America: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.5.2.1.3 South and Central America: Biobanks Market, by Application, 2019–2028 (USD Million)
10.5.3 South and Central America: Biobanks Market Share by Country – 2021 & 2028, (%)
10.5.3.1 Brazil: Biobanks Market- Revenue and Forecasts To 2028 (USD Million)
10.5.3.1.1 Overview
10.5.3.1.2 Brazil: Biobanks Market- Revenue and Forecasts To 2028 (USD Million)
10.5.3.1.3 Brazil: Biobanks Market, by Product, 2019–2028 (USD Million)
10.5.3.1.3.1 Brazil: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.5.3.1.3.2 Brazil: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.5.3.1.3.3 Brazil: Biobanks Market, by Services, 2019–2028 (USD Million)
10.5.3.1.4 Brazil: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.5.3.1.5 Brazil: Biobanks Market, by Application, 2019–2028 (USD Million)
10.5.3.2 Argentina: Biobanks Market- Revenue and Forecasts To 2028 (USD Million)
10.5.3.2.1 Overview
10.5.3.2.2 Argentina: Biobanks Market- Revenue and Forecasts To 2028 (USD Million)
10.5.3.2.3 Argentina: Biobanks Market, by Product, 2019–2028 (USD Million)
10.5.3.2.3.1 Argentina: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.5.3.2.3.2 Argentina: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.5.3.2.3.3 Argentina: Biobanks Market, by Services, 2019–2028 (USD Million)
10.5.3.2.4 Argentina: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.5.3.2.5 Argentina: Biobanks Market, by Application, 2019–2028 (USD Million)
10.5.3.3 Rest of South and Central America: Biobanks Market - Revenue and Forecast to 2028 (USD Million)
10.5.3.3.1 Overview
10.5.3.3.2 Rest of South and Central America: Biobanks Market - Revenue and Forecast to 2028 (USD Million)
10.5.3.3.3 Rest of South and Central America: Biobanks Market, by Product, 2019–2028 (USD Million)
10.5.3.3.3.1 Rest of South and Central America: Biobanks Market, by Equipment, 2019–2028 (USD Million)
10.5.3.3.3.2 Rest of South and Central America: Biobanks Market, by Consumables, 2019–2028 (USD Million)
10.5.3.3.3.3 Rest of South and Central America: Biobanks Market, by Services, 2019–2028 (USD Million)
10.5.3.3.4 Rest of South and Central America: Biobanks Market, by Sample, 2019–2028 (USD Million)
10.5.3.3.5 Rest of South and Central America: Biobanks Market, by Application, 2019–2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Biobanks Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Biobanks Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Tecan Trading AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Hamilton Company
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Avantor, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 MICRONICS JAPAN CO.,LTD.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BD
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Taylor-Wharton
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Brooks Automation, Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Biovault Family
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Promega Corporation
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 SciSafe Inc.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. R&D Investments by Major Pharmaceuticals Companies
Table 2. R&D Investments by PhRMA Member Companies, 2018
Table 3. R&D Investments of PhRMA Member Companies, by Trial Stage, 2018
Table 4. North America Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 6. North America Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 7. North America Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 8. North America Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 9. North America Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. US Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 11. US Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 12. US Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 13. US Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 14. US Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 15. US Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Canada: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 17. Canada Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 18. Canada Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 19. Canada Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 20. Canada Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 21. Canada Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 22. Mexico: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 23. Mexico Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 24. Mexico Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 25. Mexico Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 26. Mexico Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 27. Mexico Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 28. Europe: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 29. Europe: Biobanks Market, by Equipment– Revenue and Forecast to 2028 (US$ Million)
Table 30. Europe: Biobanks Market, by Consumables– Revenue and Forecast to 2028 (US$ Million)
Table 31. Europe: Biobanks Market, by Services– Revenue and Forecast to 2028 (US$ Million)
Table 32. Europe: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
Table 33. Europe: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 34. Germany: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 35. Germany: Biobanks Market, by Equipment – Revenue and Forecast to 2028 (US$ Million)
Table 36. Germany: Biobanks Market, by Consumables – Revenue and Forecast to 2028 (US$ Million)
Table 37. Germany: Biobanks Market, by Services – Revenue and Forecast to 2028 (US$ Million)
Table 38. Germany: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
Table 39. Germany: Biobanks Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 40. France: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 41. France: Biobanks Market, by Equipment– Revenue and Forecast to 2028 (US$ Million)
Table 42. France: Biobanks Market, by Consumables– Revenue and Forecast to 2028 (US$ Million)
Table 43. France: Biobanks Market, by Services – Revenue and Forecast to 2028 (US$ Million)
Table 44. France: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
Table 45. France: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 46. UK: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 47. UK: Biobanks Market, by Equipment– Revenue and Forecast to 2028 (US$ Million)
Table 48. UK: Biobanks Market, by Consumables– Revenue and Forecast to 2028 (US$ Million)
Table 49. UK: Biobanks Market, by Services– Revenue and Forecast to 2028 (US$ Million)
Table 50. UK: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
Table 51. UK: Biobanks Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 52. Italy: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 53. Italy: Biobanks Market, by Equipment– Revenue and Forecast to 2028 (US$ Million)
Table 54. Italy: Biobanks Market, by Consumables– Revenue and Forecast to 2028 (US$ Million)
Table 55. Italy: Biobanks Market, by Services– Revenue and Forecast to 2028 (US$ Million)
Table 56. Italy: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
Table 57. Italy: Biobanks Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 58. Spain: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 59. Spain: Biobanks Market, by Equipment– Revenue and Forecast to 2028 (US$ Million)
Table 60. Spain: Biobanks Market, by Consumables– Revenue and Forecast to 2028 (US$ Million)
Table 61. Spain: Biobanks Market, by Services– Revenue and Forecast to 2028 (US$ Million)
Table 62. Spain: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
Table 63. Spain: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 64. Rest of Europe: Biobanks Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 65. Rest of Europe: Biobanks Market, by Equipment– Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of Europe: Biobanks Market, by Consumables– Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Europe: Biobanks Market, by Services– Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Europe: Biobanks Market, by Sample– Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Europe: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 70. Asia Pacific Biobanks Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 71. Asia Pacific Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 72. Asia Pacific Biobanks Market, by Consumables– Revenue and Forecast to 2028 (USD Million)
Table 73. Asia Pacific Biobanks Market, by Services– Revenue and Forecast to 2028 (USD Million)
Table 74. Asia Pacific Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 75. Asia Pacific Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 76. China: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 77. China Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 78. China Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 79. China Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 80. China: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 81. China: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 82. Japan: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 83. Japan Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 84. Japan Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 85. Japan Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 86. Japan: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 87. Japan: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 88. India: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 89. India Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 90. India Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 91. India Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 92. India: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 93. India: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 94. South Korea: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 95. South Korea Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 96. South Korea Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 97. South Korea Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 98. South Korea: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 99. South Korea: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 100. Australia: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 101. Australia Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 102. Australia Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 103. Australia Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 104. Australia: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 105. Australia: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of Asia Pacific: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 107. Rest of Asia Pacific Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 108. Rest of Asia Pacific Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 109. Rest of Asia Pacific Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 110. Rest of Asia Pacific: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 111. Rest of Asia Pacific: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 112. Middle East & Africa: Biobanks Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 113. Middle East & Africa: Biobanks Market, by Equipment– Revenue and Forecast to 2028 (US$ Million)
Table 114. Middle East & Africa: Biobanks Market, by Consumables– Revenue and Forecast to 2028 (US$ Million)
Table 115. Middle East & Africa: Biobanks Market, by Services– Revenue and Forecast to 2028 (US$ Million)
Table 116. Middle East & Africa: Biobanks Market Revenue and Forecasts to 2028, By Sample (US$ Million)
Table 117. Middle East & Africa: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 118. UAE: Biobanks Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 119. UAE: Biobanks Market, by Equipment– Revenue and Forecast to 2028 (US$ Million)
Table 120. UAE: Biobanks Market, by Consumables– Revenue and Forecast to 2028 (US$ Million)
Table 121. UAE: Biobanks Market, by Services– Revenue and Forecast to 2028 (US$ Million)
Table 122. UAE: Biobanks Market Revenue and Forecasts to 2028, By Sample (US$ Million)
Table 123. UAE: Biobanks Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 124. Saudi Arabia: Biobanks Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 125. Saudi Arabia: Biobanks Market, by Equipment– Revenue and Forecast to 2028 (US$ Million)
Table 126. Saudi Arabia: Biobanks Market, by Consumables– Revenue and Forecast to 2028 (US$ Million)
Table 127. Saudi Arabia: Biobanks Market, by Services– Revenue and Forecast to 2028 (US$ Million)
Table 128. Saudi Arabia: Biobanks Market Revenue and Forecasts to 2028, By Sample (US$ Million)
Table 129. Saudi Arabia: Biobanks Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 130. South Africa Biobanks Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 131. South Africa: Biobanks Market, by Equipment– Revenue and Forecast to 2028 (US$ Million)
Table 132. South Africa: Biobanks Market, by Consumables– Revenue and Forecast to 2028 (US$ Million)
Table 133. South Africa: Biobanks Market, by Services– Revenue and Forecast to 2028 (US$ Million)
Table 134. South Africa: Biobanks Market Revenue and Forecasts to 2028, By Sample (US$ Million)
Table 135. South Africa: Biobanks Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 136. Rest of Middle East & Africa: Biobanks Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 137. Rest of Middle East & Africa: Biobanks Market, by Equipment– Revenue and Forecast to 2028 (US$ Million)
Table 138. Rest of Middle East & Africa: Biobanks Market, by Consumables– Revenue and Forecast to 2028 (US$ Million)
Table 139. Rest of Middle East & Africa: Biobanks Market, by Services– Revenue and Forecast to 2028 (US$ Million)
Table 140. Rest of Middle East & Africa: Biobanks Market Revenue and Forecasts to 2028, By Sample (US$ Million)
Table 141. Rest of Middle East and Africa: Biobanks Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 142. South and Central America: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 143. South and Central America: Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 144. South and Central America: Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 145. South and Central America: Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 146. South and Central America: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 147. South and Central America: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 148. Brazil: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 149. Brazil Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 150. Brazil Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 151. Brazil Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 152. Brazil: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 153. Brazil: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 154. Argentina: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 155. Argentina Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 156. Argentina Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 157. Argentina Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 158. Argentina: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 159. Argentina: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 160. Rest of South and Central America: Biobanks Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 161. Rest of South and Central America Biobanks Market, by Equipment – Revenue and Forecast to 2028 (USD Million)
Table 162. Rest of South and Central America Biobanks Market, by Consumables – Revenue and Forecast to 2028 (USD Million)
Table 163. Rest of South and Central America Biobanks Market, by Services – Revenue and Forecast to 2028 (USD Million)
Table 164. Rest of South and Central America: Biobanks Market, by Sample – Revenue and Forecast to 2028 (USD Million)
Table 165. Rest of South and Central America: Biobanks Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 166. Organic Developments Done By Companies
Table 167. Inorganic Developments Done By Companies
Table 168. Glossary of Terms
LIST OF FIGURES
Figure 1. Biobanks Market Segmentation
Figure 2. Biobanks Market, By Region
Figure 3. Global Biobanks Market Overview
Figure 4. Equipment Segment Held Largest Share of Product And Service Segment in Biobanks Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Biobanks Market, by Geography (US$ Million)
Figure 7. Global Biobanks Market- Leading Country Markets (US$ Million)
Figure 8. Global Biobanks Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Global Biobanks Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 16. Global Biobanks Market – By Geography Forecast and Analysis – 2021 - 2028
Figure 17. Market Positioning of Key Players in Global Biobanks Market
Figure 18. Global Biobanks Market, by Product and Service, 2021 & 2028 (%)
Figure 19. Equipment: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Storage Equipment: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Sample Analysis Equipment: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Sample Processing Equipment: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Sample Transport Equipment: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Consumables: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Storage Consumables: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Analysis Consumables: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Processing Consumables: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Collection Consumables: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Services: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Storage Services: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Processing Services: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Transport Services: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Supply Services: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Software: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Global Biobanks Market Share by Application - 2021 & 2028 (%)
Figure 36. Blood Products: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. Human Tissues: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. Cell Lines: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 39. Others: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. Global Biobanks Market Share by Application - 2021 & 2028 (%)
Figure 41. Regenerative Medicine: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 42. Life Science Research: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 43. Clinical Research: Biobanks Market Revenue and Forecasts To 2028 (US$ Million)
Figure 44. North America: Biobanks Market, by Key Country – Revenue (2021) (USD Million)
Figure 45. North America Biobanks Market Revenue and Forecast to 2028 (USD Million)
Figure 46. North America: Biobanks Market, by Country, 2021 & 2028 (%)
Figure 47. US: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Canada: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Mexico: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Europe: Biobanks Market, by Key Country – Revenue (2021) (US$ Million)
Figure 51. Europe: Biobanks Market Revenue and Forecast to 2028 (US$ Million)
Figure 52. Europe: Biobanks Market, by Country, 2021 & 2028 (%)
Figure 53. Germany: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. France: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. UK: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Italy: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Spain: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Rest of Europe: Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Asia Pacific: Biobanks Market, by Key Country – Revenue (2021) (USD Million)
Figure 60. Asia Pacific Biobanks Market Revenue and Forecast to 2028 (USD Million)
Figure 61. Asia Pacific: Biobanks Market, by Country, 2021 & 2028 (%)
Figure 62. China: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. Japan: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. India: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. South Korea: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. Australia: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Rest of Asia Pacific: Biobanks Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. Middle East & Africa Biobanks Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 69. Middle East & Africa Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 70. Middle East & Africa Biobanks Market Revenue and Forecasts to 2028, By Country (%)
Figure 71. UAE: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 72. Saudi Arabia: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 73. South Africa: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 74. Rest of Middle East and Africa: Biobanks Market Revenue and Forecasts to 2028 (US$ Million)
Figure 75. South and Central America: Biobanks Market, By Key Country – Revenue (2021) (USD Million)
Figure 76. South and Central America: Biobanks Market- Revenue and Forecasts To 2028 (USD Million)
Figure 77. South and Central America: Biobanks Market Share by Country – 2021 & 2028, (%)
Figure 78. Brazil: Biobanks Market- Revenue and Forecasts To 2028 (USD Million)
Figure 79. Argentina: Biobanks Market- Revenue and Forecasts To 2028 (USD Million)
Figure 80. Rest of South and Central America: Biobanks Market - Revenue and Forecast to 2028 (USD Million)
Figure 81. Impact of COVID-19 Pandemic in North American Country Markets
Figure 82. Impact of COVID-19 Pandemic in European Country Markets
Figure 83. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 84. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 85. Impact Of COVID-19 Pandemic in South and Central America Country Markets
Figure 86. Growth Strategies Done by the Companies in the Market (%)
The List of Companies - Biobanks Market
- THERMO FISHER SCIENTIFIC INC.
- Tecan Trading AG
- QIAGEN
- Hamilton Company
- Avantor, Inc.
- MICRONICS JAPAN CO., LTD.
- BD
- Taylor-Wharton
- Brooks Automation, Inc
- Biovault Family
- Promega Corporation
- SciSafe Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For